发明名称 New water-soluble 2-(2,6-di:oxo-3-piperidinyl)-1H-iso-indole-1-di:one deriv. - may be administered parenterally and have comparable activity to thalidomide itself
摘要 Thalidomide derivs. of formula (I) and/or their salts, in racemic or optically active form, are new R1, R2 = 1-6C alkyl; or R1 + R2 = CH2CH2XCH2CH2; R3 = H or Me; X = O or NH. USE/ADVANTAGE - (I) have immunosuppresive and immunomodulating activity comparable, at least, to thalidomide itself. (I) are more water-soluble than thalidomide so that lower side effects are to be expected. Admin. is esp. parenteral. For example, for treatment of leprosy, colitis ulceroso or graft-versus-host diseases, medicaments contg. (I) can be administered intravenously, intradermally, intramuscularly or intranasally.
申请公布号 DE4211812(A1) 申请公布日期 1992.10.22
申请号 DE19924211812 申请日期 1992.04.08
申请人 GRUENENTHAL GMBH, 5100 AACHEN, DE 发明人 EGER, KURT, PROF. DR., 7400 TUEBINGEN, DE;EHNINGER, GERHARD, PROF. DR., 7405 DETTENHAUSEN, DE;STUHLER, ALFRED, DR., 7902 BLAUBEUREN, DE
分类号 A61K31/445;A61K31/4427;A61K31/5377;A61P31/04;A61P31/12;A61P37/00;A61P37/04;C07D401/04 主分类号 A61K31/445
代理机构 代理人
主权项
地址